Marco Macchia - Search Results

Year	Number of Results
2002	2
2003	10
2004	6
2005	3
2006	5
2007	1
2008	3
2009	2
2010	3
2011	8
2012	3
2013	7
2014	5
2015	11
2016	7
2017	7
2018	8
2019	9
2020	8
2021	8
2022	2

1

An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present).

Bononi G, Poli G, Rizzolio F, Tuccinardi T, Macchia M, Minutolo F, Granchi C. Bononi G, et al. Among authors: macchia m. Expert Opin Ther Pat. 2021 Feb;31(2):153-168. doi: 10.1080/13543776.2021.1841166. Epub 2020 Nov 1. Expert Opin Ther Pat. 2021. PMID: 33085920 Review.

2

Rational Development of MAGL Inhibitors.

Granchi C, Rizzolio F, Caligiuri I, Macchia M, Martinelli A, Minutolo F, Tuccinardi T. Granchi C, et al. Among authors: macchia m. Methods Mol Biol. 2018;1824:335-346. doi: 10.1007/978-1-4939-8630-9_20. Methods Mol Biol. 2018. PMID: 30039417

3

Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery.

Gado F, Meini S, Bertini S, Digiacomo M, Macchia M, Manera C. Gado F, et al. Among authors: macchia m. Future Med Chem. 2019 Aug;11(15):2019-2037. doi: 10.4155/fmc-2019-0005. Future Med Chem. 2019. PMID: 31517528 Review.

4

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.

Gado F, Digiacomo M, Macchia M, Bertini S, Manera C. Gado F, et al. Among authors: macchia m. Medicines (Basel). 2018 Aug 15;5(3):91. doi: 10.3390/medicines5030091. Medicines (Basel). 2018. PMID: 30111755 Free PMC article. Review.

5

Three-Dimensional Interactions Analysis of the Anticancer Target c-Src Kinase with Its Inhibitors.

Jha V, Macchia M, Tuccinardi T, Poli G. Jha V, et al. Among authors: macchia m. Cancers (Basel). 2020 Aug 18;12(8):2327. doi: 10.3390/cancers12082327. Cancers (Basel). 2020. PMID: 32824733 Free PMC article. Review.

6

Estrogen receptor ligands: a patent review update.

Paterni I, Bertini S, Granchi C, Macchia M, Minutolo F. Paterni I, et al. Among authors: macchia m. Expert Opin Ther Pat. 2013 Oct;23(10):1247-71. doi: 10.1517/13543776.2013.805206. Epub 2013 May 29. Expert Opin Ther Pat. 2013. PMID: 23713677 Review.

7

Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB₂R modulators in neurodegenerative diseases.

Ferrisi R, Ceni C, Bertini S, Macchia M, Manera C, Gado F. Ferrisi R, et al. Among authors: macchia m. Pharmacol Res. 2021 Aug;170:105607. doi: 10.1016/j.phrs.2021.105607. Epub 2021 Jun 3. Pharmacol Res. 2021. PMID: 34089867 Review.

8

Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review.

Gado F, Digiacomo M, Salsano JE, Macchia M, Manera C. Gado F, et al. Among authors: macchia m. Curr Med Chem. 2021 Oct 25;28(33):6730-6752. doi: 10.2174/0929867328666210324160324. Curr Med Chem. 2021. PMID: 33761849 Review.

9

Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies.

Lapillo M, Tuccinardi T, Martinelli A, Macchia M, Giordano A, Poli G. Lapillo M, et al. Among authors: macchia m. Int J Mol Sci. 2019 Feb 27;20(5):1023. doi: 10.3390/ijms20051023. Int J Mol Sci. 2019. PMID: 30818741 Free PMC article.

10

Estrogen receptor β ligands: recent advances and biomedical applications.

Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA. Minutolo F, et al. Among authors: macchia m. Med Res Rev. 2011 May;31(3):364-442. doi: 10.1002/med.20186. Med Res Rev. 2011. PMID: 19967775 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results